For example, IDH1 mutations in the population of young AML patients are found in approximately 6–10% of cases, while, in geriatric patients, the frequency of IDH1 mutations is estimated at approximately 17% [12]. This evidence concerns the gene IDH1 and acute myeloid leukemia.